Prognostic significance of the coagulation and complement systems in critical COVID-19 infection
A Ray, KAK Winter, DSL Naik, C Okorie - Prague Medical Report, 2023 - karolinum.cz
Infection with the SARS-CoV-2 virus (COVID-19 disease) can cause a wide range of clinical
situations–from an asymptomatic state to fatal outcomes. In cases of serious clinical …
situations–from an asymptomatic state to fatal outcomes. In cases of serious clinical …
Real‐Life Use of Tocilizumab in the Treatment of Severe COVID‐19 Pneumonia
R Alex, SM Gulam, K Kumar - Advances in Virology, 2022 - Wiley Online Library
Introduction. Coronavirus disease 2019 (COVID‐19) can progress to severe respiratory
compromise and lead to mortality due to induction of cytokine storm. Tocilizumab (TCZ) is …
compromise and lead to mortality due to induction of cytokine storm. Tocilizumab (TCZ) is …
Effectiveness of different treatment regimens on patients with COVID-19, hospitalized in Sanandaj hospitals: a retrospective cohort study
Objectives Different drugs have different effects on the prognosis of patients with COVID-19.
This study aimed to evaluate the effect of different drug regimens on patients with COVID-19 …
This study aimed to evaluate the effect of different drug regimens on patients with COVID-19 …
[HTML][HTML] Clinical Course and Outcomes of COVID-19 Patients Admitted to the ICU of a Tertiary Care Hospital in Central India: A Cross-Sectional Study
Background: Coronavirus disease 2019 (COVID-19) rapidly spread globally, leading to a
pandemic significantly impacting individuals, communities, and economies worldwide …
pandemic significantly impacting individuals, communities, and economies worldwide …
[HTML][HTML] Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study
AM Al-Qaaneh, FH Al-Ghamdi, S AbdulAzeez… - Pharmaceutics, 2022 - mdpi.com
Severe acute respiratory coronavirus-2 (SARS-CoV-2) still presents a public threat and puts
extra strain on healthcare facilities. Without an effective antiviral drug, all available treatment …
extra strain on healthcare facilities. Without an effective antiviral drug, all available treatment …
Clinical course of COVID-19 patients admitted to the Intensive Care Unit of a tertiary care hospital in Central India
A Modi Asati, R Patel, K Singhal, C Jain - medRxiv, 2023 - medrxiv.org
Background COVID-19 pandemic also known as Corona virus pandemic, is caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2). In India, the first case of …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2). In India, the first case of …
[PDF][PDF] Коронавірусна хвороба: дослідження, лікування, вплив на суспільство: бібліогр. зарубіж. літ./Нац. б-ка України імені ВІ Вернадського; уклад. АО Жабін …
УАО Жабін, РТІ Арсеєнко, ТВ Симоненко - irbis-nbuv.gov.ua
Останні два роки Землю вразила глобальна пандемія SARS-CoV-2, яка не оминула
жодної країни. Через небажання застосування соціальних обмежень та інших …
жодної країни. Через небажання застосування соціальних обмежень та інших …
[PDF][PDF] Les facteurs pronostiques des malades COVID-19 admis au service de réanimation médicale
H HABOUZ - 1995 - wd.fmpm.uca.ma
Les facteurs pronostiques des malades COVID-19 admis au service de réanimation médicale
Page 1 Année 2021 Thèse N216 Les facteurs pronostiques des malades COVID-19 admis au …
Page 1 Année 2021 Thèse N216 Les facteurs pronostiques des malades COVID-19 admis au …